Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;4(4):695-700.
doi: 10.3892/ol.2012.817. Epub 2012 Jul 23.

Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C

Affiliations

Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C

Shu-Pei Ma et al. Oncol Lett. 2012 Oct.

Abstract

We aimed to investigate the correlations between lymphangiogenesis, cyclooxygenase (COX)-2 and vascular endothelial growth factor-C (VEGF-C) in non-Hodgkin's lymphoma (NHL) and their associations with the clinical parameters of patients. A total of 75 patients diagnosed with NHL were enrolled in this study. Of the 75 patients, 14 (18.7%) had low-grade and 61 (81.3%) had aggressive lymphoma. We examined the immunohistochemical expression of COX-2 and VEGF-C and estimated lymphangiogenesis by counting lymphatic vessels expressing lymph vessel endothelial hyaluronan receptor-1 (LYVE-1). Our results showed that lymphatic vessel density (LVD) was positive in 59.0% of the cases with aggressive morphology, while the LVD positive rate of indolent lymphoma was only 28.6% (P=0.039). Both COX-2 and VEGF-C were correlated with lymphangiogenesis (P=0.030 and 0.000, respectively). The expression levels of COX-2 and VEGF-C were significantly correlated (P=0.015). LVD, COX-2 and VEGF-C were not correlated with the gender, age, lactate dehydrogenase (LDH) levels, β2 microglobulin (β2M) levels, extranodal involvement, disease stage, B symptoms or international prognostic index of the patients. In conclusion, lymphangiogenesis was correlated with aggressive histology in NHL. COX-2 and VEGF-C are inducers of lymphangiogenesis and their expression levels were correlated in NHL.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
LYVE-1-stained lymphatic vessels in DLBCL. (A) Lymphatic vessels showed positive staining (black arrows) while blood vessels (red arrows) containing erythrocytes were negative. Original magnification, ×200. (B) Lymphatic vessels with open lumina and linear lymphatic vessels without lumen structure were both positive for LYVE-1. Original magnification, ×100. LYVE-1, lymph vessel endothelial hyaluronan receptor-1; DLBCL, diffuse large B-cell lymphoma.
Figure 2.
Figure 2.
COX-2 expression in DLBCL. Original magnification, ×200. COX-2, cyclooxygenase-2; DLBCL, diffuse large B-cell lymphoma.
Figure 3.
Figure 3.
VEGF-C expression in DLBCL. Original magnification, ×200. VEGF-C, vascular endothelial growth factor-C; DLBCL, diffuse large B-cell lymphoma.

References

    1. Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insight into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006;25:677–694. - PubMed
    1. Cao Y, Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother. 2007;61:534–539. - PubMed
    1. Raica M, Ribatti D. Targeting tumor lymphangiogenesis: an update. Curr Med Chem. 2010;17:698–708. - PubMed
    1. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140:460–476. - PubMed
    1. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5:74–80. - PubMed